Clinical trial
Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
NCT00053040 · Pediatric Brain Tumor Consortium, Other · Withdrawn
Key facts
| NCT number | NCT00053040 |
|---|---|
| Title | Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas |
| Official title | Phase I/II Trial Of Intracerebral IL13-PE38QQR Infusions In Pediatric Patients With Recurrent Malignant Glioma |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Procedure |
| Interventions | cintredekin besudotox, conventional surgery |
| Enrollment | 0 |
| Start date | Oct 1, 2005 |
| First posted | Jan 28, 2003 |
| Last update posted | Sep 24, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: